IndraLab

Statements


COPS6 activates activity. 1 / 1
| 1

sparser
"Because KRAS is an upstream regulator of these two pathways, KRAS mutations will continue to activate both RAS-MAPK and AKT pathways to stabilize CSN6, which in turn activates β-catenin activity to cause pathogenesis in colon cancer."